Naylor Amy J, McGettrick Helen M, Maynard William D, May Philippa, Barone Francesca, Croft Adam P, Egginton Stuart, Buckley Christopher D
Rheumatology Research Group, Centre for Translational Inflammation Research, University of Birmingham, Birmingham, West Midlands, United Kingdom.
Rheumatology Research Group, Centre for Translational Inflammation Research, University of Birmingham, Birmingham, West Midlands, United Kingdom; Systems Science for Health, University of Birmingham, Birmingham, West Midlands, United Kingdom.
PLoS One. 2014 Sep 22;9(9):e107146. doi: 10.1371/journal.pone.0107146. eCollection 2014.
CD248 (Endosialin) is a type 1 membrane protein involved in developmental and pathological angiogenesis through its expression on pericytes and regulation of PDGFRβ signalling. Here we explore the function of CD248 in skeletal muscle angiogenesis. Two distinct forms of capillary growth (splitting and sprouting) can be induced separately by increasing microcirculatory shear stress (chronic vasodilator treatment) or by inducing functional overload (extirpation of a synergistic muscle). We show that CD248 is present on pericytes in muscle and that CD248-/- mice have a specific defect in capillary sprouting. In contrast, splitting angiogenesis is independent of CD248 expression. Endothelial cells respond to pro-sprouting angiogenic stimulus by up-regulating gene expression for HIF1α, angiopoietin 2 and its receptor TEK, PDGF-B and its receptor PDGFRβ; this response did not occur following a pro-splitting angiogenic stimulus. In wildtype mice, defective sprouting angiogenesis could be mimicked by blocking PDGFRβ signalling using the tyrosine kinase inhibitor Imatinib mesylate. We conclude that CD248 is required for PDGFRβ-dependant capillary sprouting but not splitting angiogenesis, and identify a new role for CD248 expressed on pericytes in the early stages of physiological angiogenesis during muscle remodelling.
CD248(内唾液酸蛋白)是一种1型膜蛋白,通过其在周细胞上的表达以及对血小板衍生生长因子受体β(PDGFRβ)信号的调节,参与发育性和病理性血管生成。在此,我们探究CD248在骨骼肌血管生成中的功能。两种不同形式的毛细血管生长(分支和出芽)可分别通过增加微循环剪切应力(慢性血管扩张剂治疗)或诱导功能过载(切除协同肌)来诱导。我们发现CD248存在于肌肉中的周细胞上,且CD248基因敲除小鼠在毛细血管出芽方面存在特定缺陷。相比之下,分支血管生成与CD248的表达无关。内皮细胞通过上调缺氧诱导因子1α(HIF1α)、血管生成素2及其受体TEK、血小板衍生生长因子-B(PDGF-B)及其受体PDGFRβ的基因表达来响应促出芽血管生成刺激;而在促分支血管生成刺激后,这种反应并未发生。在野生型小鼠中,使用酪氨酸激酶抑制剂甲磺酸伊马替尼阻断PDGFRβ信号可模拟出芽血管生成缺陷。我们得出结论,CD248是PDGFRβ依赖性毛细血管出芽所必需的,但不是分支血管生成所必需的,并确定了CD248在肌肉重塑过程中生理血管生成早期阶段在周细胞上表达的新作用。